Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-02-22 @ 6:43 PM
Study NCT ID:
NCT00237120
Status:
COMPLETED
Last Update Posted:
2009-11-23
First Post:
2005-10-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy, Safety and Long-term Prognosis of Imatinib in Patients Newly Diagnosed With Chronic Myelogenous Leukemia (Chronic Phase)
Sponsor:
Novartis
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CSTI571AJP02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
External Affairs
Old Organization:
Novartis